Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • tccbrm
    Junior Member
    • Mar 2010
    • 2

    Question about solexa sequencing

    Hi all,

    I am a new here, hope everyone can have a nice day!

    Here is my question, before sequencing, we have to make some libraries in different insert size. Is that the short insert size (200 ~500 bp) are using single-end sequencing for the alignment of contigs, and the long insert size (over 2kb) are using paie-end sequencing for joining the contigs into scaffolds?

    Thanks in advance

    Man
  • simonandrews
    Simon Andrews
    • May 2009
    • 870

    #2
    If you're using the Illumina platform for sequencing then your choice of insert size is limited by the technique used to generate the clusters on the flowcell. Generally your inserts have to be <800bp to produce usable clusters so you don't really have the option to use longer inserts.

    Comment

    • tccbrm
      Junior Member
      • Mar 2010
      • 2

      #3
      So, if I want to sequence a species, is it neccessary to senquence the single-end or what I can do is just the pair-end sequencing then align the reads?

      Thanks

      Comment

      • kmcarr
        Senior Member
        • May 2008
        • 1181

        #4
        Originally posted by simonandrews View Post
        If you're using the Illumina platform for sequencing then your choice of insert size is limited by the technique used to generate the clusters on the flowcell. Generally your inserts have to be <800bp to produce usable clusters so you don't really have the option to use longer inserts.
        This is true for the Illumina paired-end protocol, in which you sequence both ends of a contiguous stretch to DNA. But Illumina also has the mate-pair protocol which allows you to get paired reads separated by 2-5kbp.

        Comment

        • drio
          Senior Member
          • Oct 2008
          • 323

          #5
          Originally posted by kmcarr View Post
          This is true for the Illumina paired-end protocol, in which you sequence both ends of a contiguous stretch to DNA. But Illumina also has the mate-pair protocol which allows you to get paired reads separated by 2-5kbp.
          Anyone cares to talk about its experience with that protocol? How stable is it?
          -drd

          Comment

          • kmcarr
            Senior Member
            • May 2008
            • 1181

            #6
            Originally posted by drio View Post
            Originally posted by kmcarr View Post
            This is true for the Illumina paired-end protocol, in which you sequence both ends of a contiguous stretch to DNA. But Illumina also has the mate-pair protocol which allows you to get paired reads separated by 2-5kbp.
            Anyone cares to talk about its experience with that protocol? How stable is it?
            We have done it once and it mostly worked as expected. That is to say the vast majority of reads were properly paired and spaced ~2.8-3.0 kbp apart. However we observed and extreme bias in the nucleotide composition at the start of the reads. I posted about this in another thread (see here) but unfortunately got no hits there. I to am very interested in hearing what other's experiences have been with the mate-pair protocol.

            Comment

            • drio
              Senior Member
              • Oct 2008
              • 323

              #7
              Originally posted by kmcarr View Post
              We have done it once and it mostly worked as expected. That is to say the vast majority of reads were properly paired and spaced ~2.8-3.0 kbp apart. However we observed and extreme bias in the nucleotide composition at the start of the reads. I posted about this in another thread (see here) but unfortunately got no hits there. I to am very interested in hearing what other's experiences have been with the mate-pair protocol.
              I'll get back to you on that.. I have to double check.
              Ping me if I don't reply in the next couple of days.
              I'll reply to your other post.
              -drd

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                by SEQadmin2


                Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                The systematic characterization of the human proteome has
                ...
                07-20-2026, 11:48 AM
              • SEQadmin2
                Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by SEQadmin2



                Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                ...
                07-09-2026, 11:10 AM
              • SEQadmin2
                Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                by SEQadmin2



                Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                07-08-2026, 05:17 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, 07-20-2026, 11:10 AM
              0 responses
              14 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-13-2026, 10:26 AM
              0 responses
              31 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-09-2026, 10:04 AM
              0 responses
              42 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-08-2026, 10:08 AM
              0 responses
              27 views
              0 reactions
              Last Post SEQadmin2  
              Working...